Eloy Taglieri

ORCID: 0000-0003-1039-793X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Pancreatitis Pathology and Treatment
  • Neuroendocrine Tumor Research Advances
  • Gallbladder and Bile Duct Disorders
  • Gastrointestinal disorders and treatments
  • Gastric Cancer Management and Outcomes
  • Lung Cancer Research Studies
  • Intestinal Malrotation and Obstruction Disorders
  • Oral and Maxillofacial Pathology
  • Esophageal and GI Pathology
  • Gastrointestinal Tumor Research and Treatment
  • Dermatological and COVID-19 studies
  • Sarcoma Diagnosis and Treatment
  • Tracheal and airway disorders
  • Bone Tumor Diagnosis and Treatments
  • Vascular Malformations and Hemangiomas
  • Metastasis and carcinoma case studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Medical Imaging and Pathology Studies
  • Cancer Diagnosis and Treatment
  • Soft tissue tumor case studies
  • Childhood Cancer Survivors' Quality of Life
  • Dysphagia Assessment and Management
  • Intraperitoneal and Appendiceal Malignancies
  • Colorectal Cancer Screening and Detection

AC Camargo Hospital
2016-2025

Grupo Hospitalar Conceição
2017-2024

Universidade Nove de Julho
2018-2023

Universidade Federal de São Paulo
2023

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2023

Hangzhou First People's Hospital
2020

Zhejiang University
2020

University of Pennsylvania
2020

Hospital São Paulo
2019

Clinics Hospital of Ribeirão Preto
2019

Objectives: We compared the performance of AGA-2015, ESG-2018, and IAP-2024 guidelines in referring patients for surgery versus surveillance when applied to incidental after diagnosis by EUS-FNA. Methods: Single-center, retrospective study with prospective data collection. PLs identified incidentally on CT or MRI/MRCP performed other diseases inconclusive imaging results were eligible analysis. After EUS-FNA microhistological diagnosis, each was applied; sensitivity, specificity, positive...

10.1097/mpa.0000000000002456 article EN Pancreas 2025-01-13

Abstract Background and study aims There are rare data on the usefulness of endosonography-guided tissue acquisition (EUS-TA) in patients with pancreatic cystic lesions (PCLs). This aimed to determine accuracy EUS-TA ProCore 20G (PC20) for differentiating between mucinous neoplasia (MN) non-MNs (n-MN) identifying malignant PCLs, as well its adverse events (AEs) PCLs without a classificatory diagnosis by imaging exams. Patients methods In this observational, retrospective, single-center...

10.1055/a-2240-0678 article EN cc-by-nc-nd Endoscopy International Open 2024-01-01

Abstract Acute pancreatitis (AP) is a common adverse event (AE) of endoscopic papillectomy (EP). Prophylactic plastic pancreatic stent (PPS) placement appears to prevent AP. We evaluated factors associated with post-EP AP by retrospective analysis patients tumors the duodenal papilla who underwent EP from January 2008 November 2016 at 2 tertiary care centers. Clinical, laboratory, ultrasound parameters, and PPS were evaluated. Seventy-two (37 men), mean age 60.3 (31–88) years. Mean main duct...

10.1038/s41598-020-60941-3 article EN cc-by Scientific Reports 2020-03-05

Objective This study aimed to analyze the usefulness of endoscopic ultrasound–guided fine-needle aspiration (EUS-FNA) microhistology detect malignancy in pancreatic cystic lesions (PCLs). Methods Patients with PCLs were identified and submitted EUS-FNA from January 2010 2017. The percentage samples suitable for diagnostic classification by positive negative likelihood ratios asymptomatic (APC) symptomatic (SPC) determined. Results Endoscopic was performed 510 patients. resulting material...

10.1097/mpa.0000000000001525 article EN Pancreas 2020-04-01

Background and aims Escalating an indication of EUS for diagnosis treatment justifies the evaluation conditions associated with adverse events (AE) related deaths. The aim is to evaluate compare incidence AE deaths after diagnostic-EUS (D-EUS) interventional-EUS (I-EUS).Methods This retrospective study included patients undergoing D-EUS I-EUS, in two centers 28 years (03/1992 12/2019). Were noted parameters such as: age, gender, EUS, modality, time occurrence severity AE, type imposed...

10.1080/00365521.2020.1792975 article EN Scandinavian Journal of Gastroenterology 2020-07-14

This paper presents a retrospective comparison of plastic versus metallic stents in the drainage malignant distal biliary obstructions. We compared single (SPS), multiple (MPS), and (SEMS) regarding clinical decrease TB < 2.0 mg/dL, long-term patency, adverse event. 58 patients (38 women) with MDBO were included. Diagnoses 44 pancreatic adenocarcinoma (74.6%), 9 metastasis (15.5%), 3 neuroendocrine tumors (5.1%), 2 major papilla (3.4%). The number included SPS, MPS, SEMS was 17, 6, 35,...

10.1155/2017/7621821 article EN cc-by Gastroenterology Research and Practice 2017-01-01

Compare the 22G needle versus EchoTip ProCore® 20 (Cook Medical, Bloomington, IN, USA) on their handling, specimen suitability, amount of tissue obtained, diagnostic performance, possibility immunohistochemistry, and rate adverse events.This is a retrospective, comparative study consecutively examined patients with pancreatic masses who underwent endosonography-guided fine aspiration (FNA) via needle, acquisition (TA) ProCore (PC20). The operator evaluated insertion subjectively classified...

10.7759/cureus.41576 article EN Cureus 2023-07-08

Endoscopic ultrasonography is used in the diagnosis and treatment of digestive diseases adults. In children, its use limited due to a lack available expertise.This study aimed evaluate clinical impact endoscopic on diagnostic therapeutic strategy changes pediatric patients.Over ten years, this retrospectively consecutively analyzed children aged ≤18 years who underwent because inconclusive imaging or laboratory tests. The indications, results, occurrence adverse events, procedures were...

10.1590/s0004-2803.202204000-82 article EN cc-by-nc Arquivos de Gastroenterologia 2022-12-01

The International Association of Pancreatology recommends that main duct intraductal papillary mucinous neoplasm (IPMN) be treated with partial pancreatectomy [1] if surgical margins are negative for high-grade dysplasia (HGD) and invasive carcinoma, avoiding total [2]. However, it is difficult to determine the exact resection during duodenopancreatectomy IPMN. latest guidelines recommend SpyGlass obtain precise measures margin extension before surgery [1].

10.1055/a-1234-6094 article EN Endoscopy 2020-09-02

Rectal neuroendocrine tumors (R-NET) represent the most frequent of gastroenteropancreatic neoplasms (NEN-GEP) according to United States Surveillance, Epidemiology, and End Results database. With an annual percentage occurrence increasing 8.2% all rectal neoplasms, R-NET affect less than 2% are reported in only 0.05% 0.07% patients undergoing colorectal cancer (CRC) screening. The primary objective this study was assess risk factors associated with greater 10 mm. As a secondary objective,...

10.5152/tjg.2021.19910 article EN The Turkish Journal of Gastroenterology 2021-09-10

Gastric and esophagogastric junction adenocarcinoma are responsible for approximately 13.5% of cancer-related deaths. Given the fact that these tumors not typically detected until they already in advanced stages, neoadjuvancy plays a fundamental role improving long-term survival. Identification those with complete pathological response (pCR) after neoadjuvant chemotherapy (NAC) is major challenge, effects on organ preservation, extent resection, additional surgery. There little or no...

10.1590/0102-672020210002e1616 article EN cc-by ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2021-01-01

To study the clinic value of ASCA, AMCA, ACCA, ALCA-IgG, pANCA and FC for diagnosis differential IBD.METHODS: Serum faecal samples were obtained from 42 patients with CD, 27 UC, 17 normal controls.ASCA, AMCA-IgG, ACCA-IgA, pANCA, ESR, CRP detected by enzyme-linked immunosorbent assays. RESULTS:Individual detection: Positive rates ASCA-IgG in UC group 23.8%, 3.7%, 5.9%, there is significant difference between CD groups(=4.958,P < 0.05).Positive AMCA-IgG three groups 61.9%, 0%, other two...

10.1111/den.13598 article EN Digestive Endoscopy 2020-02-01
Coming Soon ...